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Abstract
Bronchopulmonary dysplasia (BPD) is a common chronic lung disease and major risk factor for severe respiratory syncytial
virus (RSV) infection among preterm infants. The Toll-like receptor 4 (TLR4) is involved in oxidative injury responses in the
lungs. Two non-synonymous single nucleotide polymorphisms in the TLR4 gene have been associated with RSV infection in
children. However, it is unclear to what extent this association is confounded by BPD or prematurity. In this study, we
analyzed two population-based cohorts of preterm infants at risk for BPD as well as ethnicity-matched infants born at term,
to test whether the TLR4 polymorphisms Asp299Gly (rs4986790) and Thr399Ile (rs4986791) are independently associated
with BPD or premature birth. In a Canadian cohort (n=269) composed of a majority of Caucasian preterm infants (BPD
incidence of 38%), the TLR4-299 heterozygous genotype was significantly under-represented in infants without BPD (1.6%
of infants versus 12% in infants with severe BPD) after adjusting for twins, ethnicity, gestational age, birth weight and
gender (p=0.014). This association was not replicated in a Finnish cohort (n=434) of premature singletons or first-born
siblings of Caucasian descent, although the incidence of BPD was substantially lower in this latter population (15%). We did
not detect a significant association (.2-fold) between TLR4 genotypes and prematurity (p.0.05). We conclude that these
TLR4 genotypes may have, at best, a modest influence on BPD severity in some populations of high-risk preterm infants.
Further studies are warranted to clarify how clinical heterogeneity may impact genetic susceptibility to BPD.
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Introduction
Bronchopulmonary dysplasia (BPD) is a serious chronic
inflammatory lung disease frequently observed in premature
infants born at less than 32 weeks of gestation [1]. Children
suffering from BPD have considerably increased risk of severe
airway disease due to respiratory syncytial virus (RSV) infection.
Nearly half of preterm infants with BPD require hospitalization
due to RSV in the first year of life compared to fewer than 5% of
term-born children less than 6 months of age [2,3]. RSV is the
most frequent cause of mortality due to respiratory infection in
children under 2 years of age [4]. Passive immunoprophylaxis
using palivizumab, a humanized monoclonal antibody directed
against the F protein of RSV, effectively reduces disease severity in
high-risk populations [5,6]. However, its high cost limits its
availability, therefore it is paramount to understand why some
infants appear to be at increased risk for severe disease [7].
Genetic factors likely play an important role in determining
susceptibility to respiratory disease such as BPD or RSV [8]. The
innate immune Toll-like receptor 4 (TLR4) gene has been directly
implicated in the immune response against RSV [9,10]. Two
common non-synonymous polymorphisms (minor allele frequency
,3%) in the human TLR4 gene (referred to as Asp299Gly and
Thr399Ile based on the amino acid permutations they encode) are
in strong linkage disequilibrium and potentially impact function of
the receptor [11,12]. Examination of a large group of premature
infants with symptomatic RSV, including 41% of premature
infants with BPD, showed that the frequency of double
heterozygous TLR4-299/-399 genotypes was substantially greater
(89.5%) compared to literature controls (,10.5%) [13]. However,
in children born at term, our group and others observed only a
modest increase in these two TLR4 genotypes (16% and 17%) in
relation with severe RSV infection or no significant increase at all
[14,15,16,17]. Taken together, these data suggest that there may
be a relatively large confounding association between the TLR4-
299/-399 genotypes and BPD, or even prematurity.
BPD involves an arrested vascular and alveolar pulmonary
development, exacerbated by inflammation and oxidative lung
injury [1]. Recently, twin studies also demonstrated a strong
heritability [18,19]. Because genetic risk factors appear to play an
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important risk factor for RSV infection, a confounding genetic
association is plausible. A potential modulation of the BPD severity
due to functional variants in the TLR4 gene is also consistent with
an emerging appreciation of the role of TLR4 in protecting lung
tissue against oxidative damage ([20,21] and see discussion). In this
study, we aim to determine whether there is an independent
epidemiological association between TLR4 polymorphisms and
BPD in two cohorts of at-risk preterm infants.
Results
Association between TLR4 genotypes and BPD
Preterm cohort A consisted of 269 preterm infants (mean
gestational age: 27.061.8 weeks; mean birth weight: 10236315
grams). Of these infants, 65% were of Caucasian origin (see
complete ethnic distribution in Table 1) and 34% (n=94) were
twins including 72 concordant (same-sex) twins. The overall
incidence of infants with moderate or severe BPD was 38%
(n=103 out of 269). Of the infants in preterm cohort A, 246 (91%)
were alive at 36 weeks post-menstrual age (PMA). Causes of death
before 36 weeks post-menstrual age (PMA) in infants in preterm
cohort A included early severe intraventricular hemorrhage,
necrotizing enterocolitis or sepsis; none of which were thought
to be directly from BPD and therefore, these infants were excluded
from the BPD outcome definition.
In preterm cohort A, a majority of TLR4-299 heterozygous
genotypes were observed in infants with moderate or severe BPD
(60%; [95%CI: 41% to 85%]) compared to infants without BPD
(i.e. defined as no oxygen at 28 days or 36 weeks; 5%; [95%CI:
0.01% to 25%]). The frequency of combined heterozygous/rare
homozygous TLR4-299 genotype was greater in preterm neonates
with moderate or severe BPD (n=103) compared to preterm
neonates without BPD (n=62) used as a control group (12%
versus 1.6%; p=0.016; Table 2). When considering only
neonates with severe BPD (n=32), the frequency of either
combined heterozygous/rare homozygous TLR4-299 or TLR4-
399 genotypes were even higher (16%; p=0.008 and p=0.032,
respectively). Only one preterm neonate was homozygous for the
rare TLR4-299 allele; this infant had severe BPD and required
prolonged mechanical ventilation for over 45 days. Altogether,
these data indicate a potential genetic association between the two
TLR4-299 and 2399 genotypes and BPD severity.
The association between the TLR4 genotypes and BPD severity
remained significant after adjusting for twins, gestational age, birth
weight, gender, Caucasian origin and recruitment centre
Table 1. Ethnicity of infants in preterm cohort A and matched control term infants.
Ethnicity, n (%)
Preterm cohort A
(n=269)
Term-born
(n=201) 95%CI for difference (%)
{
Combined heterogenous/rare homozygous
genotypes, n (%; 95%CI)*
Asian/Oriental 27 (10) 34 (17) 213 to 20.5 NF
Black/African 6 (2.2) 4 (2.0) 22.4 to 2.9 2 (20; 3 to 56)
Caucasian/European 176 (65) 145 (72) 215 to 1.7 32 (10; 6.9 to 13)
First Nations 34 (13) 2 (1.0) 7.5 to 16 3 (10; 2 to 23)
Indian/Pakistani 10 (3.7) 8 (4.0) 23.8 to 3.4 3 (20; 4 to 41)
Latin American 3 (1.1) 5 (2.5) 23.8 to 1.1 NF
Middle Eastern 5 (1.9) 3 (1.5) 22.0 to 2.7 NF
undeclared 8 (3.0) 0 1.0 to 5.0 1 (13; 0 to 53)
{Differences considered statistically significant are underlined.
*Combined heterogenous/rare homozygous genotype includes both preterm and infants born at term. NF = none found. The term ‘‘First Nations’’ refers to Canadian
Indigenous Nations as defined by the Government of Canada.
doi:10.1371/journal.pone.0031351.t001
Table 2. Association between TLR4 genotypes and BPD in preterm cohort A.
Clinical characteristic
No BPD
(n=62)
Mild BPD
(n=81)
Moderate or
Severe BPD (n=103)
Death ,36 weeks
PMA (n=23)
95%CI for
difference
1 p value
1
GA, mean 6 SD, wk 28.761.4 27.461.4 26.161.6 2561.5 23.1 to 22.1
{
BW, mean 6 SD, g 13016244 10996259 8666263 7106135 2516 to 2354
Gender, n (%) male 24 (39) 44 (54) 49 (48) 15 (65) 26.6 to 24
Ethnicity, n (%) Caucasian 44 (71) 50 (61) 66 (64) 14 (61) 222 to 7.7
Centre, n (%) from B 16 (26) 40 (49) 40 (39) 14 (61) 21.4 to 27
Genotype*
TLR4-299, n (%) 1 (1.6) 7 (8.6) 12 (12) 2 (8.7) 3.1 to 17 0.016
TLR4-399, n (%) 2 (3.2) 6 (7.4) 12 (12) 2 (8.7) 0.8 to 16 0.06
GA: Gestational age; BW: Birth weight; 95%CI: 95% confidence interval.
*Combining heterozygous/rare homozygous genotypes.
{Statistically significant differences are underlined;
1Comparing the Moderate/Severe with the No BPD group.
doi:10.1371/journal.pone.0031351.t002
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when adjusting for blood culture-positive post-natal sepsis, as well
as for antenatal chorioamnionitis (data not shown). Clinical
characteristics of preterm infants recruited in either of the two
recruitment centres in cohort A were comparable except for a
higher proportion with severe BPD from Centre A (Table 4). In
order to control for population heterogeneity, we repeated the
regression analysis using the same co-variables, but including only
Caucasian children. In this analysis, we confirmed the association
between TLR4 genotype and BPD severity (p=0.020 for both
TLR4-299 and TLR4-399 genotypes).
Replication of the TLR4 genotype association with BPD
In order to replicate the TLR4-BPD association detected in
Preterm cohort A, we examined another population-based cohort
of Finnish infants. Preterm cohort B consisted of 434 singletons or
first-born sibling infants alive at 36 weeks PMA (mean gestational
age: 29.562.1 weeks; mean birth weight: 12686375 grams). The
incidence of infants with BPD requiring supplemental oxygen at
36 weeks PMA was generally low (15%). In these infants, the
proportions of genotypes in infants with or without BPD were
similar and we did not detect a similar association between either
TLR4-299 and 2399 genotypes and BPD severity (Table 5).
TLR4 genotype and prematurity
In order to examine potential associations between TLR4
genotypes and prematurity in preterm cohort A, infants were
compared to a control group of term-born neonates matched by
self-declared maternal ethnicity. As expected, both TLR4-299 and
2399 heterozygous variants highly co-segregated (.99% of cases)
Table 3. Multiple regression analysis between clinical co-
variables and TLR4-299 genotype* (dependent variable).
Co-variable Adjusted OR [95%CI] p value
Gestational age (wk) 1.12 [0.77 to 1.63] 0.56
Birth weight (g) 1.00 [1.00 to 1.00] 0.78
Gender (male or female) 0.95 [0.36 to 2.49] 0.92
Ethnicity, (Caucasian or not) 1.05 [0.39 to 2.81] 0.93
Recruitment Centre (A or B) 0.50 [0.19 to 1.32] 0.16
BPD (none, mild, moderate or severe) 2.15 [1.17 to 3.97] 0.014
*Results are shown for combined heterozygous/rare homozygous genotypes in
binary regression. Significance was also comparable using all three genotypes
(Asp/Asp, Asp/Gly and Gly/Gly) in regression models using BPD (p=0.016) as
the dependent variable.
doi:10.1371/journal.pone.0031351.t003
Table 5. Association between TLR4 genotypes and BPD in preterm cohort B.
Clinical characteristic No BPD (n=311) Mild BPD (n=56) Moderate BPD (n=52) Severe BPD (n=15) p value
{
GA, mean 6 SD, wk 30.161.6 27.461.8 28.262.2 28.362.0
BW, mean 6 SD, g 13776344 9606265 10086327 9886307
Gender, % male 59 46 65 80
Genotype*
TLR4-299, n (%) 61 (20) 10 (18) 16 (31) 3 (20) 0.31
TLR4-399, n (%) 61 (20) 10 (18) 16 (31) 3 (20) 0.31
GA: Gestational age; BW: Birth weight;
*Combining heterozygous/rare homozygous genotypes.
{Chi-square or Fisher exact as indicated.
doi:10.1371/journal.pone.0031351.t005
Table 4. Clinical characteristics of infants in preterm cohort A.
Clinical characteristic Centre 1 (n=159) Centre 2 (n=110) 95%CI for difference
{
Gestational age, mean 6 SD, wk 2761.8 2761.8 246 to 46
Birth weight, mean 6 SD, g 10166329 10336294 294 to 60
Male gender, n (%) 86 (54) 49 (45) 22.6 to 22
Caucasian, n (%) 103 (65) 73 (66) 213 to 10
Death prior to 36 wks PMA, n (%) 9 (5.7) 14 (13) 214 to 0.1
BPD, n (%)* 63 (42) 40 (42) 28.5 to 15
Severe BPD, n (%)* 25 (17) 7 (7.3) 2.1 to 17
Duration of supplemental oxygen, days (median, interquartile range)
&,£ 17 (1–62) 25 (3–56) NC
Duration of mechanical ventilation, days (median, interquartile range)
£ 7 (1–27) 3 (1–17) NC
&Up to transfer to peripheral centre or discharge home.
*Based on neonates alive at 36 weeks PMA.
{Differences considered statistically significant are underlined.
£Differences were not statistically significant (p.0.05) based on non-parametric Mann-Whitney U testing. NC=Not calculated.
doi:10.1371/journal.pone.0031351.t004
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frequencies of the heterozygous TLR4-299 and 2399 genotypes in
both term-born cohort (9.5 and 9.0, respectively) and preterm
cohort A (7.8 and 8.2, respectively) were consistent with
frequencies previously reported in healthy children [13], indicating
negligible selection bias in either groups. There was no significant
difference between either TLR4-299 or 2399 genotype frequen-
cies in preterm cohort A and term-born infants (p.0.05).
Moreover, in regression analysis we did not detect associations
between gestational age, birth weight, gender or ethnicity, and
either combined 2299- or 2399 heterozygous/rare homozygous
genotype within the group of preterm neonates (p.0.05).
Discussion
In this study, we specifically addressed the influence of two
common non-synonymous TLR4 gene polymorphisms on BPD
and prematurity. An influence of TLR4-299/-399 genotypes on
BPD severity is highly biologically plausible given the major role of
this receptor in lung protection against the effects of hyperoxia and
compelling body of evidence indicating that these genotypes may
alter TLR4 responsiveness [20,21]. TLR4 is expressed by alveolar
epithelial cells [22]. Genome-wide linkage analyses have identified
this gene as a main determinant of oxidative lung injury in mice
[23]. In animal models, TLR4-deficient mice show exaggerated
susceptibility to a lethal hyperoxic lung insult [24], whereas mice
with an induced TLR4 expression demonstrate resistance to
hyperoxia [25]. Using population-based cohorts to minimize
selection bias, we found a significant association between BPD and
the TLR4-299 and 2399 genotypes in preterm infants born #30
weeks of gestation recruited in a Canadian population of mixed
ethnicity. However, this association was not replicated in a second
Finnish cohort of singletons or first-born sibling preterm infants
born ,32 weeks of gestation recruited from a homogenous
Caucasian population. In addition, a .2-fold association between
extreme prematurity and the two TLR4 polymorphisms was not
detected.
Although TLR4-299/-399 genotypes appear to have little
functional effect on peripheral blood innate immune functions
[26], apical cell surface expression of the TLR4-299Gly and 399Ile
variants was shown to be markedly reduced in primary respiratory
epithelial cells [11,27]. Functionally, the TLR4-299Gly and 399Ile
allelic variants additively impair interaction with the co-receptors
MD-2 and/or CD14; consistent with our genetic association data
the minor 2299Gly allele is reported to have a greater functional
impact than the minor 399Ile allele [12]. In the case of preterm
infants, the heterozygous TLR4 genotype is more likely to reduce
tolerance to excessive oxygen exposure in primary respiratory
tissues, therefore predisposing some infants to BPD. Consistent
with this mechanism, we found that the combined frequency of the
heterozygous and rare homozygous TLR4 genotypes was low in
infants without BPD (1.2%) compared to the term-born infants or
to previous reports in pediatric cohorts [15,16,26], which may
imply a protective role of against BPD in some populations of at-
risk preterm infants.
Replication of findings in independent populations is a widely
accepted method to exclude false-positive associations in genetic
association studies [28]. Nonetheless, given the relatively modest
statistical significance we cannot exclude that the association with
BPD observed in preterm cohort A is due to chance. Because the
TLR4 genetic association with BPD is preserved in our sensitivity
analysis of the sub-group of Caucasian in preterm cohort A, lack of
power or differences in the ethnic distribution are unlikely to
explain the differences in association between preterm cohort A
and B. Alternatively, variations in clinical practice (e.g. reduced
utilization of supplemental oxygen, increase use of non-invasive
ventilation, lower incidence of sepsis, etc.), which can be
substantial among neonatal centers, may modulate genetic
influences on BPD [29], a perspective that has not been sufficiently
addressed to date [30]. Because the potential role of the candidate
TLR4 variants in BPD is so biologically compelling and the
association is robust after correction for covariables, we believe
the latter possibility is likely. In this regard, it is noteworthy that
the incidence of BPD and especially of severe BPD, is generally
much lower in several other European countries, including Finland
(i.e. cohort B), and this may mask potential genetic effects [31]. In
order to clarify these questions, gene-environment analyses
comparing outcomes in sizeable population-based cohorts differing
in clinical practices or in the incidence of BPD is warranted.
Awomoyi and colleagues reported an association between RSV
and TLR4 genotypes of unusually high magnitude (odds ratios of
72.7; 95%CI [38.8 to 136]) [13]. Because a major proportion of
infants in this study were born preterm at high risk of BPD, these
two latter factors may have biased this association. Although we
have not directly examined the outcome of RSV disease, our study
is still important to clarify a potential large influence from these
factors. The relatively modest effect size of the combined
heterozygous/rare homozygous genotypes we detect in infants of
the preterm cohort A with severe BPD (12%), is unlikely to be
sufficient to explain the strong over representation (89.5%)
reported by Awomoyi [13]. Additional studies are required to
address whether modest associations between TLR4 polymor-
phisms and symptomatic RSV infections exist in children with or
without BPD.
With regard to a possible modest association between TLR4
variants and prematurity, slight enrichment in heterozygous/rare
homozygous TLR4-299 genotype frequencies (from 16 to 23%) has
been reported by Lorenz et al. in mid-preterm Finnish infants (i.e.
3363.5 weeks of gestation) compared to infants born at term.
More significant associations have not been detected in African
infants born earlier in gestation (,33 weeks) [32,33]. We found no
association between prematurity and TLR4-299Gly and -399Ile
alleles, however, it is important to appreciate that our cohort was
not specifically powered to detect the small difference in TLR4-299
genotype frequency reported by Lorenz et al. [32]. Therefore,
while our results are not inconsistent with these previous data, we
exclude associations between the TLR4-299/-399 polymorphisms
and prematurity, of magnitude greater than 2-fold.
In conclusion, our data support a potential modest influence of
common non-synonymous variants in the biologically-compelling
candidate gene TLR4 on BPD, in some populations of at-risk
preterm infants. Further studies are required to substantiate this
finding and/or to clarify how variations in clinical practices among
neonatal centers may influence genetic effects of TLR4 polymor-
phisms on BPD severity in preterm infants.
Methods
Study populations and method of recruitment
This study was conducted according to the principles expressed
in the Declaration of Helsinki. Parental written informed consent
was obtained for all subjects recruited in this study. This study was
approved by the University of British Columbia Clinical Research
Ethics Board, the University of Alberta Ethics Board and the
Research Ethics Board of Oulu University Hospital.
Preterm cohort A: The first preterm cohort consist of premature
neonates of mixed ethnicity (see Table 1 for a complete ethnic
distribution) born at #30 completed weeks of gestation, sequentially
TLR4 Genotypes and BPD Severity
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the neonatal intensive care unit of two large regional referral
centres: the Children’s & Women’s Health (C&W) Centre of British
Columbia (Vancouver, British Columbia, Canada) and the Royal
Alexandra Hospital (RAH, Edmonton, Alberta, Canada) at birth.
Preterm cohort B: The second preterm cohort consisted of neonates
born ,32 weeks of gestation. These were either singletons or, in
cases of multiple gestations, the first-born sibling of first degree
Finnish (a rather homogenous Caucasian population) maternal and
parental descent sequentially recruited at the University Hospital of
Oulu (Finland). These infants represent 80% of all very preterm
infants from the district of Northern Finland. In both cohorts, only
infants without major congenital anomalies of the cardiorespiratory
system in whom written parental consent could be obtained were
enrolled. Approximately 62%, 51% and 65% of eligible preterm
infants in study period were enrolled at C&W, RAH or Oulu
hospitals,respectively.Controlsforthe pretermcohortA wereterm-
born infants (.37 weeks gestation) sequentially recruited at birth
(C&W), from mothers undergoing elective repeat caesarean section
deliveries in the context of a healthy pregnancy between February
2006 and August 2007.
Clinical outcomes
Standard outcome measures that were the same between the
two populations were used to limit the possibility of misclassifica-
tion. BPD was defined as a chronic need for supplemental oxygen
at 36 weeks of post-menstrual age (PMA) or at time of discharge
home whichever came first, and further graded by severity using
criteria adapted from the National Institute of Child Health and
Human Development (NICHD) [18]. Respiratory outcome data
were retrieved from the referral institution (up to discharge of the
infant home) for all preterm neonates transferred before 36 weeks
PMA, if on supplemental oxygen therapy and/or respiratory
support for less than 72 h prior to transfer out of the main study
centres. Preterm infants with BPD of moderate to severe grades
were grouped together and compared to preterm infants without
BPD on the basis that adverse and beneficial genetic variants
would be enriched, respectively, in these two groups of disease
severity. Blood-culture positive microbial sepsis in preterm infants
was defined by clinical signs (e.g. temperature instability,
cardiorespiratory instability, intestinal intolerance, etc.) accompa-
nied with a single positive blood or cerebrospinal culture.
Chorioamnionitis was defined following examination of placental
histology, as a maternal stage 2 or greater including involvement
of fetal membranes, and according to an established standard
classification [34].
Genotyping
DNA was either obtained from cord blood, umbilical cord tissue
or peripheral blood depending on the circumstances of enrolment.
DNA extraction was carried out using the ChargeSwitch gDNA
Mini Tissue kit (Invitrogen) or the QIAamp DNA Blood Midi kit
(QIAgen). Genotyping of TLR4-299 (reference dbSNP: rs4986790)
and 2399 (reference dbSNP: rs4986791) allelic variants was
performed by real time quantitative PCR as previously described
[15]. Genotype frequencies were in Hardy-Weinberg equilibrium
(p.0.05 by chi-square test).
Statistical analyses
In order to exclude a greater than 2-fold association between
TLR4-299/-399 variants and BPD, we estimated that 200 preterm
neonates in cohort A (estimated incidence of BPD of 35%) and 350
preterm neonates in cohort B (due to a lower estimated incidence
of BPD of 20%) would be sufficient considering the ,10%
baseline TLR4 genotype frequencies reported in the general
population (power 80%; alpha error 5%). Similarly, we estimated
that 200 term-born control neonates would allow us to detect at
least a 2-fold difference in heterozygous allele frequencies between
preterm and term-born infants. To detect an association with
prematurity in preterm cohort A, infants were matched in
frequency with term-born neonates according to self-reported
maternal ethnicity. The Fisher exact or chi-square probability test
were used to determine significance of differences in proportions,
allelic or genotype frequency between groups. Multivariate
regression analyses were performed using genotype or BPD as
the dependant variable and included cited adjustment co-
variables. For the preterm cohort A, regression models were also
adjusted for twins using a co-variable defining each singleton or
twin pair. 95% confidence intervals were calculated using the
exact method. Statistics were computed using SPSS version 11.0
for Microsoft Windows.
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